Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University 87 Dingjiaqiao, Nanjing, China.
Obes Rev. 2018 Sep;19(9):1236-1247. doi: 10.1111/obr.12713. Epub 2018 Jul 23.
Obesity, a comorbid medical condition, is usually observed in patients with established coronary artery disease. Paradoxically, patients with a higher body mass index (BMI) usually have better clinical outcomes after coronary revascularization.
We searched five online databases through December 2017. We identified studies reporting the rate of all-cause mortality or cardiovascular-related outcomes among patients after coronary revascularization with percutaneous coronary intervention or coronary artery bypass graft based on various BMI categories. Network meta-analysis was performed using Bayesian methods.
Sixty-five records involving 865,774 participants were included in our study. A U-shaped association was observed across BMI categories for all-cause mortality. Using normal weight as the reference, all-cause mortality was increased for (relative risk [RR]: 2.4; 95% credibility interval [CrI]: 2.1-2.7) patients with underweight, whereas it was lowered in patients with overweight, obese, and severely obese. This association remained significant in many subgroups. We also observed that the risk of major adverse cardiovascular events (MACE) was lowest among patients with overweight. Furthermore, patients with underweight were associated with greater risks of myocardial infarction (RR: 1.9; 95% CrI: 1.4-2.5), cardiovascular-related mortality (RR: 2.8; 95% CrI: 1.6-4.7), stroke (RR: 2.0; 95% CrI: 1.3-3.3) and heart failure (RR: 1.7; 95% CrI: 1.1-2.7) compared with normal weight patients; no significant association was observed among individuals with higher BMI.
The 'obesity paradox' does exist in patients after coronary revascularization, especially for patients with post-percutaneous coronary intervention. All-cause mortality in patients with high BMI is significantly lower compared with patients with normal weight. Furthermore, patients with underweight experience higher rates of cardiovascular outcomes compared with patients with normal weight.
肥胖是一种合并症,通常见于已确诊冠心病的患者。但矛盾的是,体重指数(BMI)较高的患者在冠状动脉血运重建后通常具有更好的临床结局。
我们通过在线数据库检索至 2017 年 12 月,检索报告了经皮冠状动脉介入治疗或冠状动脉旁路移植术后,按不同 BMI 类别分组的患者全因死亡率或心血管相关结局的研究。采用贝叶斯方法进行网状荟萃分析。
我们的研究纳入了 65 项记录,涉及 865774 名患者。全因死亡率呈 BMI 类别 U 型关联。与正常体重者相比,体重过低者(RR:2.4;95%置信区间[CrI]:2.1-2.7)全因死亡率增加,超重、肥胖和重度肥胖者则降低。该关联在许多亚组中仍具有统计学意义。我们还发现,超重患者发生主要不良心血管事件(MACE)的风险最低。此外,体重过低患者与心肌梗死(RR:1.9;95%CrI:1.4-2.5)、心血管相关死亡率(RR:2.8;95%CrI:1.6-4.7)、卒中和心力衰竭(RR:2.0;95%CrI:1.3-3.3)的风险增加相关,与正常体重患者相比;而 BMI 更高者则无显著关联。
在冠状动脉血运重建后的患者中,确实存在“肥胖悖论”,尤其是经皮冠状动脉介入治疗后的患者。与正常体重患者相比,高 BMI 患者的全因死亡率显著降低。此外,体重过低患者的心血管结局发生率高于正常体重患者。